Mopac
Facts
- HQ
- Seattle, Washington
Is this your organization? Claim it
Insights from Uncommon Thinkers: How these innovators found novel approaches in their fields
This week on the GeekWire Podcast, we sit down with some of the Seattle region’s “Uncommon Thinkers” — inventors, scientists, technologists and entrepreneurs transforming industries and driving positive change in the world. We recorded the episode on location, backstage at the GeekWire Gala, where we recognized five Uncommon Thinkers through this annual awards program, presented in partnership with Greater Seattle Partners. Speaking on the episode are: Uri Shumlak, co-founder and chief scientist at Zap Energy, a physicist leading a team in pursuit of fusion energy, taking a different approach from others in the field. Read the profile. Ingrid Swanson Pultz…
Fundamentals for Startups: The PvP Biologics story: A molecule from concept to commercial use
(https://comotion.uw.edu) Dr. Ingrid Swanson Pultz described the founding and spinning out of her company, PvP Biologics, from the UW's Institute for Protein Design and its eventual acquisition by Takeda Pharmaceuticals. She discussed the key points that led to the success of PvP and described the challenges encountered throughout their journey. Dr. Ingrid Swanson Pultz is Chief Technology Officer at Mopac Biologics and a Translational Advisor at the Institute for Protein Design (IPD). She was Chief Scientific Officer of PvP Biologics, an IPD spin out company acquired by Takeda Pharmaceuticals in 2020, and served as the CEO for PvP in its…
People
-
Ingrid Swanson Pultz Executive, Chief Technology Officer